John‐Bjarne Hansen

6.7k total citations
194 papers, 4.5k citations indexed

About

John‐Bjarne Hansen is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, John‐Bjarne Hansen has authored 194 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Internal Medicine, 88 papers in Hematology and 75 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in John‐Bjarne Hansen's work include Venous Thromboembolism Diagnosis and Management (126 papers), Blood Coagulation and Thrombosis Mechanisms (80 papers) and Atrial Fibrillation Management and Outcomes (34 papers). John‐Bjarne Hansen is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (126 papers), Blood Coagulation and Thrombosis Mechanisms (80 papers) and Atrial Fibrillation Management and Outcomes (34 papers). John‐Bjarne Hansen collaborates with scholars based in Norway, Netherlands and United States. John‐Bjarne Hansen's co-authors include Sigrid K. Brækkan, Tom Wilsgaard, Inger Njølstad, Ellisiv B. Mathiesen, Kristin F. Enga, Kristian Hindberg, Per Morten Sandset, Maja‐Lisa Løchen, Ellen Brodin and Vânia M. Morelli and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

John‐Bjarne Hansen

186 papers receiving 4.4k citations

Peers

Countries citing papers authored by John‐Bjarne Hansen

Since Specialization

Citations

This map shows the geographic impact of John‐Bjarne Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John‐Bjarne Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John‐Bjarne Hansen more than expected).

Fields of papers citing papers by John‐Bjarne Hansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John‐Bjarne Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John‐Bjarne Hansen. The network helps show where John‐Bjarne Hansen may publish in the future.

Co-authorship network of co-authors of John‐Bjarne Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of John‐Bjarne Hansen. A scholar is included among the top collaborators of John‐Bjarne Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John‐Bjarne Hansen. John‐Bjarne Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Elevated Plasma MBL Levels Are Associated With Risk of Future Venous Thromboembolism: The HUNT Study 2025 ·Arteriosclerosis Thrombosis and Vascular Biology ·(unknown), (unknown), Omri Snir, Kristian Hindberg, Sigrid K. Brækkan, Steven P. Grover, Therese Haugdahl Nøst, Péter Gál, Gábor Pál, Christian Jonasson, Peter Garred, Tom Eirik Mollnes, Kristian Hveem, John‐Bjarne Hansen	0
2	Plasma osteopontin levels are associated with the risk of future incident venous thromboembolism—the Trøndelag Health Study (HUNT) 2025 ·Journal of Thrombosis and Haemostasis ·Maryam Hosseini, Kristian Hindberg, Therese Haugdahl Nøst, Christian Jonasson, Kristian Hveem, John‐Bjarne Hansen, Omri Snir	0
3	Plasma miR-145-5p Levels and Risk of Future Cancer—Results from the HUNT Study 2025 ·International Journal of Molecular Sciences ·(unknown), Júlia Oto, Vânia M. Morelli, Kristian Hveem, Sigrid K. Brækkan, Pilar Medina, John‐Bjarne Hansen	1
4	Galectin-3-binding protein and future venous thromboembolism 2024 ·Research and Practice in Thrombosis and Haemostasis ·(unknown), (unknown), Pål Aukrust, Thor Ueland, John‐Bjarne Hansen, Sigrid K. Brækkan, Vânia M. Morelli	2
5	Proportion of venous thromboembolism attributed to recognized prothrombotic genotypes in men and women 2024 ·Research and Practice in Thrombosis and Haemostasis ·(unknown), (unknown), Kristian Hveem, Maiken E. Gabrielsen, John‐Bjarne Hansen, Sigrid K. Brækkan	0
6	Complement factors B, D, C3bBbP and risk of future venous thromboembolism 2023 ·Clinical Immunology ·(unknown), (unknown), (unknown), Nadezhda Latysheva, Annika E. Michelsen, Thor Ueland, Sigrid K. Brækkan, Kristian Hindberg, Omri Snir, Tom Eirik Mollnes, John‐Bjarne Hansen	2
7	Plasma levels of P-selectin and future risk of incident venous thromboembolism 2023 ·Journal of Thrombosis and Haemostasis ·(unknown), Thor Ueland, John‐Bjarne Hansen, Omri Snir, Sigrid K. Brækkan	5
8	High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolism 2023 ·Journal of Thrombosis and Haemostasis ·Steven P. Grover, Omri Snir, Kristian Hindberg, (unknown), Sigrid K. Brækkan, Vânia M. Morelli, (unknown), Alisa S. Wolberg, Tom Eirik Mollnes, Thor Ueland, Nigel Mackman, John‐Bjarne Hansen	8
9	C1 inhibitor deficiency enhances contact pathway mediated activation of coagulation and venous thrombosis 2023 ·Blood ·Steven P. Grover, Tomohiro Kawano, Jun Wan, (unknown), (unknown), (unknown), Omri Snir, Sigrid K. Brækkan, (unknown), (unknown), (unknown), Keith R. McCrae, Alisa S. Wolberg, John‐Bjarne Hansen, Henriette Farkas, Nigel Mackman	17
10	Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study 2023 ·Blood Advances ·Monique J. T. Crobach, (unknown), Sigrid K. Brækkan, Marianne Tang Severinsen, Jens Hammerstrøm, (unknown), Søren Risom Kristensen, (unknown), Anne Tjønneland, Henri H. Versteeg, Kim Overvad, John‐Bjarne Hansen, Inger Anne Næss, Suzanne C. Cannegieter	20
11	Combined effect of high factor VIII levels and high mean platelet volume on the risk of future incident venous thromboembolism 2023 ·Journal of Thrombosis and Haemostasis ·(unknown), (unknown), Pål Aukrust, Thor Ueland, John‐Bjarne Hansen, Sigrid K. Brækkan, Vânia M. Morelli	7
12	The Interaction Between Venous Thromboembolism and Socioeconomic Status on the Risk of Disability Pension 2022 ·SHILAP Revista de lepidopterología ·(unknown), Erzsébet Horváth–Puhó, Kristina Laugesen, Sigrid K. Brækkan, John‐Bjarne Hansen, Henrik Toft Sørensen	1
13	Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease 2022 ·Journal of Thrombosis and Haemostasis ·Paul L. den Exter, Scott C. Woller, Helia Robert‐Ebadi, Camila Masias, Pierre‐Emmanuel Morange, (unknown), John‐Bjarne Hansen, Geert‐Jan Geersing, Deborah Siegal, Kerstin de Wit, Frederikus A. Klok	27
14	Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study 2022 ·Journal of Thrombosis and Haemostasis ·(unknown), (unknown), Vânia M. Morelli, Maja‐Lisa Løchen, Inger Njølstad, Ellisiv B. Mathiesen, Tom Wilsgaard, John‐Bjarne Hansen, Sigrid K. Brækkan	4
15	A systematic review of biomarkers among hospitalized patients with COVID‐19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Variables Scientific and Standardization Committee of the ISTH 2022 ·Research and Practice in Thrombosis and Haemostasis ·Scott C. Woller, Kerstin de Wit, Helia Robert‐Ebadi, Camila Masias, Frederikus A. Klok, Paul L. den Exter, Pierre‐Emmanuel Morange, (unknown), John‐Bjarne Hansen	2
16	Elevated plasma concentration of complement factor C5 is associated with risk of future venous thromboembolism 2021 ·Blood ·(unknown), Sigrid K. Brækkan, Judith Krey Ludviksen, Omri Snir, Kristian Hindberg, Tom Eirik Mollnes, John‐Bjarne Hansen	15
17	Venous thromboembolism and subsequent permanent work‐related disability 2016 ·Journal of Thrombosis and Haemostasis ·Sigrid K. Brækkan, Scott D. Grosse, Ekwutosi M. Okoroh, James H. Tsai, Suzanne C. Cannegieter, Inger Anne Næss, Steinar Krokstad, John‐Bjarne Hansen, Finn Egil Skjeldestad	35
18	Increased risk of venous thrombosis after arterial thrombosis: causal or explained by common risk factors? 2013 ·Data Archiving and Networked Services (DANS) ·Linda E. Flinterman, (unknown), Marianne Tang Severinsen, Suzanne C. Cannegieter, John‐Bjarne Hansen, Kim Overvad	4
19	Impact of incident venous thromboembolism on future risk of arterial thrombotick disease 2013 ·VBN Forskningsportal (Aalborg Universitet) ·(unknown), Linda E. Flinterman, Kristin F. Enga, Marianne Tang Severinsen, Søren Risom Kristensen, (unknown), Suzanne C. Cannegieter, Kim Overvad, John‐Bjarne Hansen	1
20	Tromboseprofylakse hos pasienter på indremedisinsk sengepost 2007 ·Tidsskrift for Den Norske Laegeforening ·Sigrid K. Brækkan, Sameline Grimsgaard, John‐Bjarne Hansen	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact